Valuation Bio-Rad Laboratories, Inc.
Stocks
BIO
US0905722072
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Cboe BZX
11:39:28 2026-10-12 EDT
|
5-day change | 1st Jan Change | ||
| 361.86 USD | -1.17% |
|
-4.95% | +19.16% |
Company Valuation: Bio-Rad Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 22,439 | 12,460 | 9,399 | 9,182 | 8,212 | 9,785 | - | - |
| Change | - | -44.47% | -24.57% | -2.31% | -10.57% | 19.15% | - | - |
| Enterprise Value (EV) 1 | 22,439 | 11,868 | 8,992 | 8,730 | 7,874 | 9,036 | 8,820 | 8,678 |
| Change | - | -47.11% | -24.24% | -2.91% | -9.8% | 14.75% | -2.39% | -1.6% |
| P/E | 5.38x | - | -14.8x | -5.03x | 10.9x | 44x | 43x | 43.3x |
| PBR | - | 1.27x | 1.05x | 1.41x | 1.11x | - | - | - |
| PEG | - | - | - | -0x | -0x | -0.6x | 18.83x | -61.41x |
| Capitalization / Revenue | 7.68x | 4.45x | 3.52x | 3.58x | 3.18x | 3.81x | 3.73x | 3.69x |
| EV / Revenue | 7.68x | 4.24x | 3.37x | 3.4x | 3.05x | 3.52x | 3.36x | 3.27x |
| EV / EBITDA | 33.1x | 17.8x | 16.8x | 18.2x | 17.4x | 22.8x | 21.6x | 20.1x |
| EV / EBIT | 39.3x | 22.7x | 23.7x | 26.4x | 25.3x | 30.9x | 27.2x | 26x |
| EV / FCF | 41.9x | 127x | 24x | - | - | 28.8x | 29.9x | 26.2x |
| FCF Yield | 2.39% | 0.79% | 4.17% | - | - | 3.48% | 3.34% | 3.82% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 140.6 | - | -21.82 | -65.36 | 27.85 | 8.32 | 8.51 | 8.45 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,923 | 2,802 | 2,671 | 2,566 | 2,583 | 2,569 | 2,624 | 2,654 |
| EBITDA 1 | 677.5 | 667.9 | 535.9 | 479.5 | 453.2 | 395.8 | 408.8 | 432.6 |
| EBIT 1 | 571.2 | 524 | 378.9 | 331.3 | 311.6 | 292 | 324 | 334.4 |
| Net income 1 | 4,246 | -3,628 | -637.3 | -1,844 | 759.9 | 224.8 | 229.7 | 228.3 |
| Net Debt 1 | - | -592.5 | -407.6 | -452.1 | -337.7 | -749 | -965.4 | -1,107 |
| Reference price 2 | 755.57 | 420.49 | 322.89 | 328.51 | 302.99 | 366.16 | 366.16 | 366.16 |
| Nbr of stocks (in thousands) | 29,918 | 29,824 | 29,145 | 27,997 | 26,975 | 26,738 | - | - |
| Announcement Date | 2/10/22 | 2/16/23 | 2/15/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 44.01x | 3.52x | 22.83x | - | 9.78B | ||
| 29.16x | 3.91x | 15.12x | 2.58% | 172B | ||
| 18.92x | 3.45x | 12.33x | 3.18% | 113B | ||
| 21.59x | 4.25x | 14.82x | 1.3% | 106B | ||
| 25.92x | 2.55x | 10.24x | 2.77% | 75.31B | ||
| 17.73x | 0.21x | 12.94x | 0.73% | 61.8B | ||
| 30.68x | 7.58x | 19.64x | 1.3% | 52.93B | ||
| 35.41x | 3.42x | 11.72x | 2.14% | 50.05B | ||
| 35.08x | 8.72x | 24.53x | -.--% | 40.81B | ||
| 48.93x | 1.34x | 12.38x | 0.2% | 31.81B | ||
| Average | 30.74x | 3.89x | 15.65x | 1.58% | 71.44B | |
| Weighted average by Cap. | 27.05x | 3.81x | 14.55x | 1.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BIO Stock
- Valuation Bio-Rad Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
















